Get Premium to unlock powerful stock data
VistaGen Therapeutics Inc logo

VistaGen Therapeutics Inc

$ 1.06 +0.04 (+3.92%) 10:08 PM EST
P/E:
At Loss
P/B:
2.74
Market Cap:
$ 218.92M
Enterprise V:
$ 138.36M
Volume:
1.93M
Avg Vol (2M):
1.36M
Volume:
1.93M
Market Cap $:
218.92M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.36M
Enterprise Value $:
138.36M
PB Ratio:
2.74
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

VistaGen Therapeutics Inc
NAICS : 325412 SIC : 2834
343 Allerton Avenue, South San Francisco, CA, USA, 94080
Description
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.
Name Current Vs Industry Vs History
Cash-To-Debt 26.65
Equity-to-Asset 0.88
Debt-to-Equity 0.04
Debt-to-EBITDA -0.09
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.28
Distress
Grey
Safe
Beneish M-Score -1.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 44.46
9-Day RSI 37.74
14-Day RSI 38.81
6-1 Month Momentum % -34.87
12-1 Month Momentum % -52.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.51
Quick Ratio 13.51
Cash Ratio 13.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -99

Financials (Next Earnings Date:2022-06-29 Est.)

VTGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:VTGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.512
EPS (TTM) ($) -0.324
Beta 1.26
Volatility % 45.06
14-Day RSI 38.81
14-Day ATR ($) 0.098461
20-Day SMA ($) 1.163
12-1 Month Momentum % -52.61
52-Week Range ($) 0.9618 - 3.55
Shares Outstanding (Mil) 206.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VistaGen Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More